GSK (GSK) Stock Highlights

33.6 | +0.51%

2024-12-21 00:16:20

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Statistics

Range Today

33.04 33.87

Volume Today 6.81M

Range 1 Year

32.83 45.93

Volume 1 Year 1.03B

Range 3 Year

28.47 46.97

Volume 3 Year 3.35B

Range 10 Year

28.47 49.08

Volume 10 Year 9.73B

Highlights

Market Capitalization 69.54B (large)

Floating Shares 3.95B

Current Price 33.6

Price To Earnings 21.52

Price To Revenue 4.75

Price To Book 9.79

Earnings Per Share 1.54

Dividend Yield 4.68%

Dividend Per Share 1.56

Payout Ratio 98.54%

Performance

Latest +0.51%

1 Month +0.6%

3 Months -18.55%

6 Months -17.79%

1 Year -8.27%

3 Years -21.48%

5 Years -29.05%

10 Years -23.2%

Benchmarks

Market Capitalization

0 / 14

Gross Profits

0 / 14

Total Revenue

0 / 14

Total Rank

0 / 14

Free Cashflow

0 / 14

Performance 5 years

0 / 14

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.